My research area is vaccine impact modelling with a focus on estimating the health, economic, and equity impact of vaccination programmes to support evidence-based public health decision-making and inform vaccine policy in collaboration with partners and stakeholders at the global, regional, and national levels. I have worked on impact assessment of different vaccines, including human papillomavirus, measles, Haemophilus influenzae type b, rotavirus, pneumococcal, influenza, dengue, Strep A, typhoid, COVID-19, and basic vaccines in the childhood immunisation schedule, in varied settings of low-, middle-, and high-income countries. 

I welcome collaborations related to estimating vaccination impact in different geographic settings, and you are welcome to contact me.